AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionFalcon Wealth Planning
Latest Disclosed Ownership3,011 shares
Latest Disclosed Value $ 654,876
Falcon Wealth Planning reports 1.93% increase in ownership of 4AB / AbbVie Inc.

On April 21, 2026 - Falcon Wealth Planning filed a 13F-HR form disclosing ownership of 3,011 shares of AbbVie Inc. (DE:4AB) valued at $558,239 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,954 shares of AbbVie Inc.. This represents a change in shares of 1.93% during the quarter. The current value of the position is $559,143 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBVIE COM 00287Y109 3,011 57 1.93 655 -2.97 0.0446
2026-02-03 2025-12-31 13F ABBVIE COM 00287Y109 2,954 162 5.80 675 4.33 0.0568
2025-10-10 2025-09-30 13F ABBVIE COM 00287Y109 2,792 143 5.40 646 31.57 0.0581
2025-07-16 2025-06-30 13F ABBVIE COM 00287Y109 2,649 33 1.26 492 -10.40 0.0497
2025-04-24 2025-03-31 13F ABBVIE COM 00287Y109 2,616 254 10.75 548 30.79 0.0609
2025-01-22 2024-12-31 13F ABBVIE COM 00287Y109 2,362 -31 -1.30 420 -11.23 0.0468
2024-10-30 2024-09-30 13F ABBVIE COM 00287Y109 2,393 -551 -18.72 473 -6.35 0.0555
2024-07-16 2024-06-30 13F ABBVIE COM 00287Y109 2,944 -159 -5.12 505 -10.80 0.0656
2024-04-15 2024-03-31 13F ABBVIE COM 00287Y109 3,103 91 3.02 565 21.24 0.0896
2024-01-10 2023-12-31 13F ABBVIE COM 00287Y109 3,012 1,393 86.04 467 93.36 0.0816
2023-10-05 2023-09-30 13F ABBVIE COM 00287Y109 1,619 23 1.44 241 12.09 0.0523
2023-07-13 2023-06-30 13F ABBVIE COM 00287Y109 1,596 140 9.62 215 -7.33 0.0479
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 1,456 1,456 232 0.0579
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.